Hypoxia-inducible factors (HIFs), including HIF1, HIF2 and HIF3, are known to function in oxygen homeostasis by regulating the genes responsible for glucose uptake and metabolism, erythropoiesis, angiogenesis, apoptosis and cell proliferation.^[@bib1]^ The HIFs are heterodimeric basic-helix-loop-helix-PAS transcription factors that consist of an oxygen-regulated *α* subunit and a constitutively expressed *β* subunit, which is also known as ARNT.^[@bib1]^ In normoxic conditions, both HIF1*α* and HIF2*α* are targeted for proteosomal degradation by prolyl hydroxylase and the von Hippel--Lindau (VHL) E3 ligase complex.^[@bib2]^ When cells are subjected to hypoxia, the HIF-*α* factors are stabilized and in turn associate with ARNT and activate target genes.^[@bib2]^ HIF3*α* lacks a conventional C-terminal transactivation domain and it is postulated to act as a negative regulator of hypoxia-inducible gene expression.^[@bib3]^

Despite their oxygen homeostatic functions in adult tissues, HIF-related pathways also have critical functions in embryos. Constitutive depletion of the mouse *HIF1α* gene (*HIF1α*^−/−^) results in developmental arrest and embryonic lethality, which is characterized by neural tube defects, cardiovascular malformations, dysregulated erythropoiesis signaling, and marked cell death within the cephalic mesenchyme.^[@bib4],\ [@bib5],\ [@bib6]^ *HIF2α* null (*HIF2α*^−/−^) embryos died as a result of inadequate blood vessel fusion, remodeling and impaired fetal lung maturation.^[@bib7],\ [@bib8]^ Inhibition of *HIF2α* expression also enhanced the generation of reactive oxygen species (ROS) and reduced transcription of primary anti-oxidant enzymes (AOEs), which in turn caused a syndrome of multiple-organ pathology.^[@bib9]^ Neural cell-specific depletion of *HIF1α* resulted in hydrocephalus accompanied by an increase in neuron cell apoptosis and vascular regression in the telencephalon of mutant mouse embryos.^[@bib10]^

Depending on the severity of hypoxia, hypoxic signals may induce different responses during cell death. For the pro-apoptotic pathway, HIF1*α* conspires with p53 and/or BNIP3 to promote apoptosis.^[@bib11],\ [@bib12]^ However, hypoxia can also induce an anti-apoptotic response by increasing the expression of the anti-apoptotic protein IAP2 and suppressing the expression of the pro-apoptotic protein Bax through a HIF1*α*-independent mechanism.^[@bib13]^ A recent study has shown that HIF2*α* may be involved in the anti-apoptotic properties of tumor cells. Inhibition of HIF2*α* promoted p53 activity and induced tumor cell death by disturbing cellular redox homeostasis and promoting the accumulation of ROS.^[@bib14]^

Survivin (Birc5) is the smallest member of the inhibitor of apoptosis proteins (IAPs) and contains a single baculovirus IAP repeat (BIR) domain and an extended C-terminal *α*-helical coiled-coil domain.^[@bib15]^ In addition to inhibiting apoptosis, survivin also has important functions in cell mitosis and cell-cycle progression.^[@bib16]^ The mammalian survivin protein is widely expressed in embryonic cells, especially in neural progenitor cells, but it is barely detectable in quiescent adult cells.^[@bib17]^ During brain development, survivin is highly expressed in neural progenitor cells. Targeted deletion of *survivin* in neural precursor cells leads to massive apoptosis in the central nervous system (CNS) due to elevated caspase-3 and caspase-9 activities.^[@bib18]^ Interestingly, *survivin* is widely expressed in all kinds of malignant tumors, making it a potent target for cancer therapy.^[@bib15],\ [@bib19]^

There are multiple HIF*α* factors, including HIF1*α*, HIF2*α* and HIF3*α*, in zebrafish that are widely expressed during development.^[@bib20],\ [@bib21]^ Concurrent knockdown of these three factors leads to neural cell death and abrogates neuronal development, indicating that these HIF-*α* factors have critical roles in neural cell survival and differentiation.^[@bib20]^ Nevertheless, the authentic HIF-*α* factor responsible for the fates of CNS neuronal progenitor cells (NPCs) remains to be elucidated. Here, we demonstrate that of the three HIF-*α* factors, HIF2*α* has a major role in maintaining cell survival and promotes neural progenitor cell differentiation. HIF2*α* depletion caused massive cell death and abrogated neural cell differentiation due to aberrant expression of the *survivin* homologs (*birc5a* and *birc5b*). The surviving NPCs remained in the cell cycle. The defects that appeared in *hif2α* morphant embryos were rescued by ectopic injection of the *birc5a* or *birc5b* mRNA, suggesting that survivins act downstream of HIF2*α* to protect neural progenitor cells and promote neural differentiation. Chromatin immunoprecipitation assay revealed that HIF2*α* binds to both *birc5a* and *birc5b* promoters directly to modulate their transcriptions.

Results
=======

**HIF2*α* knockdown induces p53-independent apoptosis.** There are multiple HIF-*α* factors, including HIF1*α*, HIF2*α* and HIF3*α*, in zebrafish that are widely expressed during development.^[@bib20],\ [@bib21]^ Concurrent knockdown of these three factors leads to neural cell death and abrogates neuronal development.^[@bib20]^ To clarify the particular HIF *α* factor that determines the fates of zebrafish CNS NPCs, we analyzed apoptotic events in individual *hifα* morphant embryos. We found that knockdown of *hif2α* by either of two distinct anti-sense morpholinos resulted in massive apoptosis at the 24- and 48-h post-fertilization (h.p.f.) stage ([Figures 1a--c, g--h and t](#fig1){ref-type="fig"}). Conversely, knockdown of *hif1α* and *hif3α* either individually or concurrently did not increase the number of apoptotic cells ([Figures 1d--f, i and t](#fig1){ref-type="fig"}), indicating that HIF2*α* has a unique function in protecting embryonic cells against apoptosis.

In addition to the massive apoptosis, a morphological abnormality with small and acellular head was observed in *hif2α* morphants at the 48-h.p.f. stage ([Figure 1h](#fig1){ref-type="fig"}). During early stage of development, massive apoptosis was elicited by *hif2α* morpholino at the 12-h.p.f. stage before any morphological defect observed ([Figures 1j and k](#fig1){ref-type="fig"}). Moreover, the *pcna* expression in the anterior proliferative region was diminished at the 12-h.p.f. stage, possibly due to the considerable cell death ([Figures 1l and m](#fig1){ref-type="fig"}). It suggests that the gross developmental abnormalities observed in *hif2α* morphants is possibly caused by extensive cell death occurred in the early stage of development.

A similar anti-apoptotic function has been observed for the human HIF2*α* protein. siRNA-mediated knockdown of *HIF2α* promoted p53 activity in human tumor cells and induced cell death by disturbing the cellular redox homeostasis and prompting the accumulation of ROS.^[@bib14]^ To examine whether the *hif2α* morpholino-induced apoptosis in zebrafish embryos is mediated by p53 activity, we concurrently knocked down *p53* and *hif2α* using translational morpholinos. Our results show that the depletion of *p53* expression did not block the massive apoptosis induced by treatment with *hif2α* morpholinos ([Figures 1n and o](#fig1){ref-type="fig"}). Similarly, severe apoptosis was observed in *p53*^*M214K*^ mutant embryos after injection with a *hif2α* translation-blocking MO ([Figures 1p and q](#fig1){ref-type="fig"}), indicating that the HIF2*α* depletion-induced apoptosis is not an off-target effect of the morpholino and that it is mediated through a p53-independent pathway.

To verify whether the apoptotic cells observed in *hif2α* morphants are undifferentiated NPCs, embryos were first *in situ* hybridized with fluorescence *nestin* (*nes*) RNA probe followed by TUNEL assay. We found that most of apoptotic cells were colocalized with *nes*-positive cells (as labeled yellow in [Figures 1r and s](#fig1){ref-type="fig"}), indicating that the apoptotic cells in *hif2α* morphants are indeed NPCs.

**Knockdown of hif2*α* abrogates CNS differentiation.** We next examined the fate of the surviving NPCs in the *hifα* morphant embryos using the terminal differentiation marker *elavl3*. Knockdown of *hif2α* caused a dramatic reduction in *elavl3* transcription ([Figures 2b, c and m](#fig2){ref-type="fig"}) compared with wild-type embryos ([Figure 2a](#fig2){ref-type="fig"}) or the other two types of *hifα* morphants ([Figures 2d--f and m](#fig2){ref-type="fig"}), indicating that loss of *hif2α* expression not only stimulated NPC apoptosis but also abrogated the differentiation of these cells. The loss of neural differentiation in *hif2α* morphants was confirmed by the lack of HuC/D expression ([Figure 2h](#fig2){ref-type="fig"}) and acetylated *α*-tubulin ([Figure 2k](#fig2){ref-type="fig"}). Consistent with this observation, the *hif2α* morphants had higher transcript levels of the neural progenitor markers, such as *nes*, *sox3* and *achaete-scute complex-like 1b* (*ascl1b*), compared with control embryos in the late stages of development ([Figures 3a--f](#fig3){ref-type="fig"}), suggesting that the NPCs are retained in the undifferentiation stage. The high level of PCNA expression in CNS suggests that the undifferentiated NPCs in the *hif2α* morphants maintain a high level of proliferation ([Figures 3h and j](#fig3){ref-type="fig"}). Moreover, the reduction in the expression of the cdk inhibitors *cdkn1b* ([Figures 4a, b and g](#fig4){ref-type="fig"}) and *cdkn1c* in the CNS region ([Figures 4c, d and h](#fig4){ref-type="fig"}) was accompanied by an increase in *ccnd1* transcription ([Figures 4e, f and i](#fig4){ref-type="fig"}), indicating that the NPCs in the *hif2α* morphants did not exit normally from the cell cycle. It was further supported by double fluorescent *in situ* hybridization of *nes* and *ccnd1* expression ([Figures 4j--o](#fig4){ref-type="fig"}). The colocalization of these two gene expression in the CNS of *hif2α* morphants (yellow in [Figure 4o](#fig4){ref-type="fig"}) suggesting that most of NPCs in these *hif2α* morphants were hyperproliferating cells.

**Survivins function downstream of HIF2*α* to protect neural progenitor cells and promote neural differentiation.** Survivin is the smallest member of the IAP family and has multiple functions in cell survival, mitosis and proliferation. Knockdown of the zebrafish *survivin* orthologues *birc5a* and *birc5b* causes profound neuro-developmental, hematopoietic, cardiogenic, vasculogenic and angiogenic defects.^[@bib22]^ Together, these results suggest that survivin functions in embryonic development. In various human cancer cells, *survivin*/*BIRC5* transcription is upregulated as a result of increases in HIF1*α*.^[@bib23]^ This raises the possibility that the *survivin* orthologues in zebrafish are also affected by one of the HIF factors. Here, we analyzed the transcriptional activities of the survivin orthologues *birc5a* and *birc5b* in various *hifα* morphant embryos. In wild-type embryos, the survivin orthologues *birc5a* and *birc5b* and *hif2α* were all transcribed intensively in the CNS region ([Figures 5a--c](#fig5){ref-type="fig"}). Depletion of HIF2*α* resulted in a reduction in the transcription of both *birc5a* and *birc5b* ([Figures 5d, e, h and i](#fig5){ref-type="fig"}), indicating that *hif2α* correlates with *survivin* expression. Conversely, concurrent depletion of *hif1α* and *hif3α* did not affect the transcription of either *birc5a* or *birc5b* ([Figures 5f--i](#fig5){ref-type="fig"}). This suggests that zebrafish *survivin* orthologues are affected specifically by HIF2*α* but not by other HIF-*α* factors. To determine whether the survivin deficiency accounts for the HIF2*α* depletion-induced NPC apoptosis and aberrant neural differentiation, we examined NPC apoptosis and neural differentiation in *birc5a* and *birc5b* morphant embryos. Knockdown of either *birc5a* or *birc5b* caused considerable increases in apoptosis and morphological abnormality, which were similar to that observed in *hif2α* morphant embryos ([Figures 6a, b, g, h](#fig6){ref-type="fig"}, [7a--c](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}). Additionally, the *birc5a* and *birc5b* morphants exhibited much lower levels of *elavl3* transcription compared with WT controls ([Figures 6c, e and i--l](#fig6){ref-type="fig"}). Likewise, *birc5a* and *birc5b* morphants exhibited higher levels of *nes* and *pcna* transcription compared with controls ([Figures 9a--i](#fig9){ref-type="fig"}). Moreover, the *birc5a* and *birc5b* morphant embryos had lower levels of *cdkn1b* and *cdkn1c* transcription and higher levels of *ccnd1* transcription than control embryos ([Figures 9j--r](#fig9){ref-type="fig"}). Together, these observations indicate that knockdown of either *birc5a* or *birc5b* results in the induction of NPC apoptosis and the inhibition of cell-cycle exit in the NPCs, which is similar to the phenotype observed in the *hif2α* morphant embryos. Moreover, ectopic treatment with the *birc5a* or *birc5b* mRNA not only successfully prevented *hif2α* MO-induced apoptosis and morphological abnormality ([Figures 6m, n](#fig6){ref-type="fig"}, [7d](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}), but also restored *elavl3* expression to a nearly normal level ([Figures 6o--r](#fig6){ref-type="fig"}), indicating that the survivin orthologues indeed rescue the impairment in NPC development that is caused by HIF2*α* deficiency.

**HIF2*α* binds to *birc5a* and *birc5b* promoters.** Since depletion of HIF2*α* resulted in a reduction in the transcription of both *birc5a* and *birc5b*, it raises a possibility that HIF2*α* indeed controls the *survivin* orthologues through direct interactions with their promoters. We retrieved the upstream sequence of both *bric5a* and *birc5b* genes from UCSC genome website (<http://genome.ucsc.edu/>) and identified multiple hypoxia-response element (HRE) core sequences (A/GCGTG) in the promoter regions ([Figure 10c](#fig10){ref-type="fig"}). Similar multiple HRE core sequences were also identified in human and mouse *BIRC5* promoters ([Figure 10c](#fig10){ref-type="fig"}). To determine if zebrafish HIF2*α* binds to the HRE specifically, oligonucleotides containing the HRE core sequence ACGTG were synthesized, biotin labeled and electrophoretic mobility shift assay (EMSA) was carried out ([Figure 10a](#fig10){ref-type="fig"}). When HIF2*α* was expressed alone or it was coexpressed with ARNT1a in COS-1 cells, a mobility complex was formed with wild-type HRE probe (lanes 3 and 4). This mobility complex was effectively competed by a 200-fold molar excess of the unlabeled HRE (lane 5). Conversely, the mobility complex was, however, unaffected by a 200-fold molar excess of the unlabeled mutated HRE (lane 6). These observations demonstrated the transfected HIF2*α* binds to HRE with a sequence specificity.

To examine whether HIF2*α* binds directly to *birc5a* and *bric5b* promoter *in vivo*, we immunoprecipitated crosslinked chromatin from adult brain tissue with a HIF2*α*-specific antibody. The precipitated chromatin was then analyzed by PCR using primer pairs that amplified modules spanning the *birc5a* and *bric5b* loci. The ChIP assay demonstrated that the module 5 of *birc5a* and modules 2 and 6 of *birc5b* were significantly enriched by the HIF2*α* antibody ([Figures 10b and c](#fig10){ref-type="fig"}), suggesting that HIF2*α* binds directly to both *birc5a* and *bric5b* promoters to modulate their expressions.

Discussion
==========

HIF*α* and survivin are prominent markers in many human cancers and have critical roles in cell apoptosis and proliferation. Previously, we found that depletion of all of the HIF *α* factors caused massive apoptosis in the brains of zebrafish embryos.^[@bib20]^ Here, we showed that of the three HIF-*α* factors, HIF2*α* is the factor that modulates neural progenitor cell growth and differentiation through its downstream effects on the survivin orthologues, Birc5a and Birc5b. Depletion of HIF2*α* expression caused reductions in both of the *birc5a* and *birc5b* transcripts, which in turn elicited massive apoptosis and abrogated neural progenitor cell differentiation. Although human *survivin* (*BIRC5*) and zebrafish *survivin* orthologues (*birc5a* and *birc5b*) promoters are all enriched with multiple HREs, these *survivin* genes are modulated by different HIF *α* factors. In human cancer cells, *BIRC5* transcription is modulated by HIF1*α* through its direct binding to the HRE in the proximate promoter region.^[@bib23]^ In zebrafish, we demonstrate that both *birc5a* and *birc5b* transcriptions are controlled by HIF2*α*, but not HIF1*α*. It is noteworthy that although zebrafish HIF1*α* does not involve in NPC growth and differentiation, it still have an essential role in other developmental events. Depletion of HIF1*α* expression abrogated erythropoiesis and reduced hemoglobin content (data not shown). It suggests that the sets of HIF1*α*- and HIF2*α*-modulated genes in human and zebrafish are slightly different due to the discriminative target selectivity of HIF1*α* and HIF2*α* factors cross species.

It has been shown that HIFs have important roles in embryonic cell differentiation and proliferation.^[@bib24]^ Hypoxic preconditioning promotes embryonic stem cell neural differentiation and enhances cell survival through upregulating HIF1*α* and HIF2*α*.^[@bib25]^ However, the functions of these HIFs in cell differentiation still have not been elucidated. Here, we demonstrate that HIF2*α* depletion first causes massive NPC apoptosis and then stimulates the remaining NPCs proliferation. Nevertheless, these newly produced NPCs did not undergo final differentiation. Ectopic treatment with the *birc5a* or *birc5b* mRNA not only successfully prevented *hif2α* MO-induced apoptosis and morphological abnormality, but also restored neural differentiation. It suggests that the abrogation of differentiation is a secondary effect elicited by HIF2*α* depletion due to the loss of its downstream effectors, Birc5a and Birc5b.

Previous studies have demonstrated a close relationship between the hypoxia-signaling pathway and cell-cycle arrest in mammalian cells. For instance, either overexpression of the stable forms of HIF1*α* and HIF2*α* in murine cells or treatment of murine cells with hypoxia directly resulted in an increase in p27 transcription and cell-cycle arrest at the G1 phase.^[@bib26],\ [@bib27]^ Moreover, targeted depletion of HIF1*α* in chondrocytes resulted in decreased p57 expression, enhanced BrdU incorporation and cell death.^[@bib28]^ We demonstrate that the loss of survivin could be responsible for the reductions in p27 and p57 expression and the aberrant neural development that is observed in the *hif2α* morphant zebrafish embryos. Survivin also had a similar effect on cell differentiation in mouse erythroid development. Depletion of survivin from hematopoietic progenitor cells results in aberrant erythroid formation.^[@bib29]^ Likewise, earlier studies have demonstrated that depletion of zebrafish *birc5a* and *birc5b* transcription evoked profound neuro-developmental, hematopoietic, cardiogenic, vasculogenic and angiogenic defects.^[@bib22]^

In *Drosophila*, dying cells trigger compensatory proliferation through both initiator and effector caspase activities.^[@bib30]^ In apoptotic proliferating tissues, the initiator caspase Dronc coordinates apoptosis and compensatory proliferation through the Jun N-terminal kinase and p53 pathways, which in turn induce secretion of the mitogens Decapentaplegic (Dpp) and Wingless (Wg).^[@bib30],\ [@bib31]^ In apoptotic differentiating tissues, the effector caspases DrICE and Dcp-1 activate the hedgehog pathway to induce compensatory proliferation.^[@bib32]^ Hedgehog signaling triggers the reentry of cells that had previously exited the cell cycle.^[@bib32],\ [@bib33]^ In zebrafish embryos, knockdown of *hif2α* resulted in the loss of expression of the *survivin* orthologues, which in turn caused severe neural progenitor cell death, increased proliferation activity and abrogated neural differentiation. This phenomenon of cell death-associated proliferation and abrogation of differentiation in zebrafish embryos is analogous to what has been observed in *Drosophila* apoptosis-induced compensatory proliferation. We hypothesize that reentry into the cell cycle causes descendant cells to remain in the progenitor stage without further differentiating. These findings suggest that a key function of HIF2*α* in developing embryos is related to inhibition of neural progenitor cell death and maintenance of neural differentiation through the functions of downstream survivin orthologues ([Figure 11](#fig11){ref-type="fig"}). Depletion of HIF2*α* and the survivin orthologues causes massive neural progenitor cell death, which induces compensatory proliferation and abrogates neural differentiation.

It has been demonstrated that inhibition of human HIF2*α* promotes tumor cell death through p53 activation. HIF2*α* depletion promotes p53-mediated responses in clear cell renal cell carcinoma (ccRCC) by disrupting cellular redox homeostasis, which thereby permits ROS accumulation and DNA damage.^[@bib14]^ Although a similar level of p53 accumulation was also observed in *hif2α* morphant embryos (data not shown), we demonstrated that inhibition of p53 expression did not prevent massive apoptosis in *hif2α* morphant embryos. Similarly, HIF2*α* inhibition-induced massive apoptosis was also observed in the p53 mutant line. Instead, we demonstrated that the massive apoptosis observed in *hif2α* morphant embryos is caused by depletion of the survivin orthologues. Ectopic treatment with survivin mRNAs rescued the defects induced by HIF2*α* inhibition, indicating that survivins act downstream of HIF2*α* to maintain cell survival. It is noteworthy that expression of *survivin/BIRC5* in ccRCC was inversely correlated with cancer-specific survival.^[@bib34]^ It will be interesting to examine the correlation between *HIF2α* and *survivin* expression in ccRCC patients. Our results have shed light on how cancer cells protect themselves through the HIF and survivin pathways.

Materials and Methods
=====================

Morpholino and mRNA injection
-----------------------------

Adult zebrafish were maintained and staged as described previously.^[@bib35]^ The tp53^M214K^ fish line generated by the laboratory of Thomas Look^[@bib36]^ was obtained from the Taiwan Zebrafish Core Facility in Taiwan. All embryos were grown in 0.003% 1-phenyl-2-thiourea after 14 h.p.f. at 28.5°C to block pigmentation and mediate visualization. Morpholinos (Gene Tools, Philomath, OR, USA) were designed against *Danio rerio hif1α*, *hif2α* and *hif3α* (GenBank accession AY326951, DQ375242 and AY330295, respectively). The *birc5a*, *birc5b* and *p53* ATG-MOs were designed as described previously.^[@bib30],\ [@bib37]^ The translation-blocking morpholino (ATG-MO) sequences and dosages applied were as follows: *hif1α* ATG-MO, 5′-CAGTGACAACTCCAGTATCCATTCC (6 ng); *hif2α* ATG-MO, 5′-CGCTGTTCTCGCGTAATTCCCGCAG-3′ (6 ng); *hif3α* ATG-MO, CCTTTTCGACGTAGAGTTCACCATC (12 ng); *birc5a* ATG-MO, 5′-TGCAAGATCCATTTTGTGGGAGGTT-3′ (4 ng); *birc5b* ATG-MO, 5′-GAAGTCTTTTTTCATAACTATACAT-3′ (12 ng); *p53* ATG-MO 5′-GCGCCATTGCTTTGCAAGAATTG-3′ (9 ng). To confirm the specificity of the *hif2α* ATG-MO, a second morpholino that blocks pre-mRNA splicing of *hif2α* at the exon 2--intron 2 junction was also designed: *hif2α* SPL-MO, 5′-GACTGTGTACCTGAGTTGACGAGTT-3′ (6 ng). Aliquots of the morpholinos (4.6 nl each) were injected into 1--2 cell-stage embryos using a Drummond Nanoject (Drummond, Broomall, PA, USA). For capped RNA synthesis, the full-length cDNAs of *hif2α*, *birc5a* and *birc5b* were cloned into the pT7TS vector. After linearization, the plasmids were transcribed *in vitro* with T7 RNA polymerase and the mMESSAGE mMACHINE kit from Ambion (Austin, TX, USA). For the rescue assay, 75 pg of purified *hif2α* mRNA or 50 pg of purified *birc5a* and *birc5b* mRNAs were co-injected with *hif2α* ATG-MO into 1--2 cell-stage embryos.

*In situ* hybridization
-----------------------

The *hif2α* (DQ375242, bases 2557--3137), *birc5a* (NM_194397, bases 38--485), *birc5b* (NM_145195, bases 2--421), *elavl3*/*HuC* (BC065343, bases 55--554), *nes* (XM_001919887, bases 54--754), *pcna* (BC064299, bases 255--1367), *p27*/*cdkn1b* (NM_212792, bases 611--1262), *p57*/*cdkn1c* (NM_001002040, bases 50--1133) and *ccnd1* (NM_131025, bases 1094--2213) templates were amplified from cDNA and cloned into the pGEM-T-easy vector (Promega, Madison, WI, USA). To generate probes, the linearized plasmids were used as templates for *in vitro* transcription with the DIG RNA labeling kit (Roche Applied Science, Indianapolis, IN, USA) according to the manufacturer\'s instructions. Whole-mount *in situ* hybridization was performed essentially as described previously.^[@bib35]^ Nitro blue tetrazolium/bromo-4-chloro-3-indolyl phosphate (Roche Applied Science) served as the substrate for color development. Double fluorescent *in situ* hybridization^[@bib38]^ was performed using DIG-UTP and FITC-UTP-labeled RNA probes followed by sequential detection using HRP-labeled anti-DIG and HRP-labeled anti-FITC antibodies (Roche, Indianapolis, IN, USA) and fluorescent tyramide amplification. Following RNA probe hybridization, embryos were blocked in 10% serum, 1% BSA and were then incubated with HRP anti-FITC at 1 : 500 dilution for overnight in 10% serum, 1% BSA. After washing, anti-FITC antibody was visualized with TSA Plus Fluorescein Solution (Perkin-Elmer, Waltham, MA, USA) for 45 min, dehydrated in methanol and quenched with 1% H~2~O~2~ in methanol for 30 min. After rehydrating, embryos were blocked again and incubated with HRP anti-DIG at 1 : 500 dilution for 4 h, then washed and reacted with TSA Plus Cy3 solution (Perkin-Elmer) for 45 min. Embryos were cleared in glycerol, mounted and viewed on a Zeiss LSM 510 confocal fluorescence microscope (Zeiss, Jena, Germany).

Flow cytometric DNA content analysis
------------------------------------

After removal of the chorion and yolk, 20 embryos were washed in PBS and transferred to a collection tube. Embryos were digested with a trypsin (0.05%)/EDTA (1 mM) solution for 10 min at room temperature and then completely dissociated into single-cell suspensions by pipetting. Trypsin was inactivated by incubation with CaCl~2~ (1 mM)/lamb serum (5%), and the whole suspension was passed through a 40-*μ*m filter (BD Falcon, Franklin Lakes, NJ, USA). The cells were centrifuged at 2000 r.p.m. at 4°C, washed in PBS and fixed in 70% ethanol overnight at −20°C. After fixation, the cells were centrifuged and resuspended in PBS. The suspended cells were stained by treatment with RNase A (200 *μ*g/ml) and propidium iodide (50 ng/ml) (Sigma, St. Louis, MO, USA) for at least 15 min at 4°C in the dark. In all, 30 000 events were acquired per sample and propidium iodide-positive cells were quantified by flow cytometry (BD FACSCanto, Franklin Lakes, NJ, USA). Cells with DNA content less than that of 2 N (G0/G1) cells were classified as apoptotic cells and cells distribute between 2 and 4 N (G2/M) cells were S-phase cells.

RT-qPCR
-------

Total RNA extracted from embryos using TRIzol (Invitrogen, Carlsbad, CA, USA) followed by DNase I treatment (Roche) was used for cDNA synthesis with Superscript-II (Invitrogen). Quantitative (q)PCR was performed using the Power SIBER Q-PCR Master Mix (BioNoVas, Toronto, Canada) in a Bio-Rad, iQ5 Gradient Real Time PCR System (Bio-Rad, Hercules, CA, USA). qPCR conditions were 95°C for 3 min and then 40 cycles of 95°C for 15 s and 60°C for 1 min. The following primers were designed using the Primer Express Software version 3.0 (Applied Biosystems, Carlsbad, CA, USA):

birc5a forward, 5′-GTGGCCACGCGATTGAA-3′

birc5a reverse, 5′-CAGTCTGGATGATCTGGTTTCTCTT-3′

birc5b forward, 5′-GGAGCGACTTCGCATCTACAT-3′

birc5b reverse, 5′-ACCTCATCACGAAAGTAGGCAATC-3′

cdkn1b forward, 5′-TGGGTCGTGCCACCAATTA-3′

cdkn1b reverse, 5′-TGCATCACGTTTCACCACAGA-3′

cdkn1c forward, 5′-AACAGCACGCCGCAAATT-3′

cdkn1c reverse, 5′-TCGACTCCACGACCCTCTTT-3′

ccnd1 forward, 5′-TGTGATGAATCTCTTCGTCTTTGTT-3′

ccnd1 reverse, 5′-GTCCCATGACGCCTTTGG-3′

*β*-actin forward, 5′-CCCCGAGAGGACAACAATGTA-3′

*β*-actin reverse, 5′-TGAGGAGGGCAAAGTGGTAAA-3′.

Duplicate mean values were calculated according to the *Ct* quantification method using *β*-actin transcript levels as the reference for normalization. Relative quantification was determined using the ÄÄCt method: relative expression=2^−ΔΔCt^.

Apoptosis detection
-------------------

Zebrafish embryos at 24 h.p.f. were dechorionated and incubated for 30 min in 5 *μ*g/ml acridine orange in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl~2~ and 0.33 mM MgSO~4~). The embryos were subsequently washed repeatedly in E3 medium. For microscopic examination, embryos were transferred into 0.01% ethyl 3-aminobenzoate methanesulfonate (tricaine, Sigma). TUNEL assays were performed using an *in situ* cell death detection kit (POD, Roche) as described by the manufacturer. For combined fluorescent *nes* DIG *in situ*/TUNEL staining, embryos were first *in situ* hybridized with fluorescence *nes* RNA probe followed by TUNEL assay.^[@bib39]^ The protocol of fluorescence *in situ* hybridization is as described above. The RNA probe was labeled by DIG. After conjugated with HRP anti-DIG antibody (Perkin-Elmer), the signal was detected by TSA Plus Fluorescein Solution (Perkin-Elmer). This was followed by TUNEL assay. The embryos were manually de-yolked and the images were captured on a Zeiss LSM 510 confocal microscope.

Chromatin immunoprecipitation
-----------------------------

ChIP was performed by using Magna ChIP Protein A magnetic beads (Millipore, Billerica, MA, USA) according to the manufacturer\'s instructions. Briefly, adult brain tissues were crosslinked with formaldehyde and chromatin was isolated. The isolated chromatin was sonicated to an average size of about 200--300 bp. Protein A magnetic beads were incubated with antibody against HIF2*α* (ChIP grade rabbit polyclonal antibody purchased from GeneTex (Irvine, CA, USA), GTX103707) or control IgG at 4°C for 1 h. Immunoprecipitation reactions were performed by incubating magnetic beads-linked antibody with the chromatin overnight at 4°C. The immunoprecipitated chromatin complexes were washed with TE buffer and the protein--DNA crosslinks were reverse crosslinked by proteinase K digestion at 62°C for 2 h followed by 95°C for 10 min. The DNA was purified by spin columns and then eluted with elution buffer. Immunoprecipitated DNA and input DNA were used as templates for PCR amplification (30 cycles). The PCR primers used in ChIP assay are listed in [Table 1](#tbl1){ref-type="table"}.

Electrophoretic mobility shift assay
------------------------------------

After COS-1 cells were transfected with the indicated plasmids for 48 h, nuclear extracts were prepared by minipreparation method as described previously.^[@bib40]^ The nuclear extracts were preserved at −70°C until use. Oligonucleotide probe containing the HRE core sequence (5′-CATCGTCCTTCAA[ACGTG]{.ul}TAACTAAGTTCA-3′) and mutant probe (5′-CATCGTCCTTCAA[GTACA]{.ul}TAACTAAGTTCA-3′) was synthesized and labeled with 5′-end biotin (Purigo, Taipei, Taiwan). For each EMSA reaction, 20 *μ*g of nuclear extracts from normal or transfected COS-1 cells was mixed with biotin-labeled probes and premixed binding reagents (Thermo, Waltham, MA, USA) and incubated at room temperature for 30 min. For competitive experiments, 50 × normal and mutant probes were added. Unbound DNA probes were resolved from protein--DNA complexes by electrophoresis on a 10% polyacrylamide gel. After electrophoresis, DNA oligonucleotides were transferred onto a nylon membrane (Pall, Washington, NY, USA) and UV crosslinked. Biotin-labeled DNAs were detected by using the Lightshift Chemiluminescent EMSA Kit according to the manufacturer\'s instructions (Thermo).

Immunostaining
--------------

Zebrafish acetylated tubulin IHC was performed as described in *The Zebrafish Book.*^[@bib35]^ Briefly, embryos were fixed in 4% paraformaldehyde (PFA) at 4°C, dehydrated and stored in MeOH. After rehydration, embryos were treated with proteinase K, fixed in 4% PFA, washed in 0.3% Triton X-100 in PBS (PBT) and subsequently blocked for 1 h in PBT containing 5% horse serum. Embryos were incubated with mouse anti-acetylated tubulin antibody (1 : 1000, Sigma T-6793).^[@bib30]^ After several washes with PBT, embryos were blocked for 1 h and incubated with goat anti-rabbit Alexa Fluor 568 secondary antibody (Sigma). Images were acquired using a Zeiss *Axioskop 2* fluorescence microscope (Zeiss). For cross-sectional analysis,^[@bib35]^ embryos were embedded in OCT mount medium (Sakura Finetek, Torrance, CA, USA), Cryostat sectioned (CM-1900, Leica, Nussloch, Germany) and mounted on glass slides (Superfrost Plus, J1800AMNZ). The primary antibodies included mouse anti-HuC/HuD (Molecular Probes, Eugene, OR, USA, 1 : 1000) and monoclonal anti-PCNA (Sigma, P8825, 1 : 1000). After several washes with PBT, the slides were incubated with goat anti-rabbit Alexa Fluor 568 secondary antibody (Sigma). After repeated washes, sections were counterstained with 4,6-diamidino-2-phenylindole (DAPI, Sigma) at 10 ng/ml to visualize the nuclei. Fluorescence and UV light images were acquired using a fluorescence microscope (OLYMPUS BX 51, Olympus, Tokyo, Japan).

We thank SY Chen and CT Shih (NTOU) for critical discussions about the manuscript, J Chang (NTOU) for statistical analysis, KY Huang, WH Liao (Academia Sinica) for confocal microscope photograph, MS Yu (Taiwan Zebrafish Core Facility, NSC 99-2321-B-400-0001) for providing the tp53^M214K^ fish and YC Cheng (CGU) for reagents and fish lines. This study was supported by grants from the National Science Council (Taiwan), the Ministry of Education and the Center for the Excellence of Marine Bioenvironmental and Biotechnology (NTOU) to CHH.
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![HIF2*α* protects CNS neural progenitors from cell death. (**a**--**f**) Lateral views of acridine orange (AO) staining of wild-type (WT; **a**), *hif2α* translation-blocking MO (*hif2α* ATG-MO; **b**), *hif2α* SPL-MO (**c**), *hif1α* ATG-MO (**d**), *hif3α* ATG-MO (**e**) and *hif1α*, *hif3α* dual ATG-MO (**f**) 24 h.p.f. embryos. The apoptotic cells are labeled with white spots. (**g**--**i**) Transverse brain sections with TUNEL (bright green) and DAPI (blue) staining in WT (**g**), *hif2α* ATG-MO (**h**) and *hif1α*, *hif3α* dual ATG-MO (**i**) 48 h.p.f. embryos. (**j** and **k**) Lateral views of acridine orange (AO) staining of WT (**j**), *hif2α* ATG-MO (**k**) 12 h.p.f. embryos. (**l** and **m**) Lateral views of *pcna* expression in WT (**l**) and *hif2α* ATG-MO (**m**) 12 h.p.f. embryos. (**n** and **o**) Apoptosis analysis of *p53* ATG-MO (**n**) and *p53*, *hif2α* dual ATG-MO (**o**) 24 h.p.f. embryos by AO staining. (**p** and **q**) Apoptosis analyses of control (**p**) and *hif2α* ATG-MO (**q**) 42 h.p.f. *p53*^*M214K*^ mutant embryos by AO staining. (**r** and **s**) Colocalization of TUNEL signaling (in green) and *nes* expression (in red) in WT (**r**) and *hif2α* ATG-MO (**s**) 56 h.p.f. embryos. *nes* was stained by fluorescence *in situ* hybridization. The TUNEL-positive, *nes*-positive cells (in yellow) represent the apoptotic NPCs. (**t**) Percentages of normal, moderate and severe apoptosis in the WT control (*n*=112), *hif1α* ATG-MO (*n*=72), *hif2α* ATG-MO (*n*=114), hif2*α* SPL-MO (*n*=66), *hif3α* ATG-MO (*n*=50) and *hif1α*, *hif3α* dual ATG-MO (*n*=137) embryos](cdd201144f1){#fig1}

![Knockdown of *hif2α* impairs CNS development. (**a**--**f**) Lateral views of *elavl3* expression in WT (**a**), *hif2α* ATG-MO (**b**), *hif2α* SPL-MO (**c**), *hif1α* ATG-MO (**d**), *hif3α* ATG-MO (**e**) and *hif1α*, *hif3α* dual ATG-MO (**f**) 24 h.p.f. embryos. *elavl3* expression in the CNS was decreased greatly under the *hif2α* ATG-MO and *hif2α* SPL-MO treatments, indicating that these NPCs were not terminally differentiated. (**g**--**i**) Immunofluorescent staining of HuC/HuD (in red) in transverse brain sections of WT (**g**), *hif2α* ATG-MO (**h**) and *hif1α*, *hif3α* dual ATG-MO (**i**) 48 h.p.f. embryos. Nuclei are labeled by DAPI staining (in blue). Consistent with the mRNA transcriptional activity, knockdown of *hif2α* eliminated HuC expression, indicating a defect in neural differentiation. Knockdown of *hif2α* also caused morphological abnormality with small head. (**j**--**l**) Dorsal views of whole-mount immunostained images of acetylated *α*-tubulin in WT (**j**), *hif2α* ATG-MO (**k**) and *hif1α*/*hif3α* ATG-MO (**l**) 24 h.p.f. embryos. Axons were visualized by antibody staining for acetylated *α*-tubulin. The neural development defect following *hif2α* MO treatment was reflected by the loss of axon growth. (**m**) Percentages of normal, moderate and severe loss of *elavl3* expression in the WT control (*n*=50), *hif1α* ATG-MO (*n*=54), *hif2α* ATG-MO (*n*=69), *hif2α* SPL-MO (*n*=23), *hif3α* ATG-MO (*n*=25) and (*n*=64) embryos. Knockdown of *hif2α* with either translation-blocking or splicing-blocking MOs led to a severe loss of *elavl3* transcription, indicating impairment in neural differentiation](cdd201144f2){#fig2}

![The surviving neural progenitor cells in *hif2α* morphants continue to proliferate without terminally differentiating. (**a**--**f**) Lateral views of *nes* (**a** and **b**), *sox3* (**c** and **d**) and *ascl1b* (**e** and **f**) expression in WT (**a**, **c** and **e**) and *hif2α* ATG-MO (**b**, **d** and **f**) 48 h.p.f. embryos. *nes*, *sox3* and *ascl1b* were highly expressed in the NPCs but not in mature neural cells. The high level of *nes*, *sox3* and *ascl1b* transcriptions in *hif2α* morphants suggests that the NPCs did not differentiate into mature neural cells. (**g** and **h**) Lateral views of *pcna* transcription in WT (**g**) and *hif2α* ATG-MO (**h**) 48 h.p.f. embryos. (**i** and **j**) Immunofluorescent staining of PCNA (in red) in transverse brain sections of WT (**i**) and *hif2α* ATG-MO (**j**) 48 h.p.f. embryos. Nuclei are labeled by DAPI staining (in blue). The increased *pcna* expression in the CNS of *hif2α* MO embryos indicates that the NPCs were proliferating](cdd201144f3){#fig3}

![The surviving neural progenitor cells in *hif2α* morphants do not exit normally from the cell cycle. (**a**--**f**) Lateral views of *cdkn1b* (**a** and **b**), *cdkn1c* (**c** and **d**) and *ccnd1c* (**e** and **f**) expression in WT (**a**, **c** and **e**) and *hif2α* ATG-MO (**b**, **d** and **f**) 48 h.p.f. embryos. (**g**--**i**) Quantitative RT-PCR of the *cdkn1b* (**g**), *cdkn1c* (**h**) and *ccnd1* (**i**) genes in WT, *hif2α* ATG-MO and *hif1α*, *hif3α* dual ATG-MO 24 h.p.f. embryos. Decreased *cdkn1b* and *cdkn1c* expression and increased *ccnd1* expression in the CNS of *hif2α* morphants suggest that the NPCs failed to exit from the cell cycle. (**j**--**o**) Double fluorescent *in situ* hybridizations of *nes* (red; **j** and **k**) and *ccnd1* (green; **l** and **m**) in WT (**j**, **l** and **n**) and *hif2α* ATG-MO (**k**, **m** and **o**) 48 h.p.f. embryos. Merged images (**n** and **o**) are shown. The colocalization of *nes* and *ccnd1* (in yellow) expressions in *hif2α* morphants indicates most of surviving NPCs are hyperproliferating cells](cdd201144f4){#fig4}

![Knockdown of *hif2α* reduces the expression of the survivin orthologues. (**a**--**c**) Lateral views of *hif2α* (**a**), *birc5a* (**b**) and *birc5b* (**c**) transcription in 24 h.p.f. WT embryos. Expression of all three transcripts overlapped in the CNS region. (**d**--**g**) Lateral views of *birc5a* (**d** and **f**) and *birc5b* (**e** and **g**) expression in *hif2α* ATG-MO (**d** and **e**) and *hif1α*, *hif3α* dual ATG-MO (**f** and **g**) 24 h.p.f. embryos. The expression levels of both *birc5a* and *birc5b* were reduced in *hif2α* morphants. (**h** and **i**) Quantitative RT-PCR of the *birc5a* (**h**) and *birc5b* (**i**) genes in WT, *hif2α* ATG-MO and *hif1α*, *hif3α* dual ATG-MO 24-h.p.f. stage embryos. Expression was normalized to *β*-actin. Knockdown of *hif2α* caused a reduction in the transcription of *birc5a* and *birc5b*](cdd201144f5){#fig5}

![Survivin orthologues function downstream of HIF2*α* to control CNS development. (**a** and **b**) Transverse brain sections with TUNEL staining in 48 h.p.f. wild-type (WT; **a**) and *hif2α* ATG-MO (**b**) embryos. (**c** and **d**) Lateral views of *elavl3* expression in WT (**c**) and *hif2α* ATG-MO (**d**) 24 h.p.f. embryos. (**e** and **f**) Immunofluorescent staining of HuC/HuD (in red) in transverse brain sections of WT (**e**) and *hif2α* ATG-MO (**f**) 48 h.p.f. embryos. Nuclei are labeled by DAPI staining (in blue). (**g** and **h**) Transverse brain sections with TUNEL staining in *birc5a* ATG-MO (**g**) and *birc5b* ATG-MO (**h**) 48 h.p.f. embryos. Knockdown of *birc5a* and *birc5b* induced CNS apoptosis. (**i** and **j**) Lateral views of *elavl3* expression in *birc5a* ATG-MO (**i**) and *birc5b* ATG-MO (**j**) 24 h.p.f. embryos. Compared with WT, *birc5a* and *birc5b* MO embryos exhibited lower *elavl3* expression, and a similar pattern was found in *hif2α* MO embryos. (**k** and **l**) Immunofluorescent staining of HuC/HuD in transverse brain sections of *birc5a* ATG-MO (**k**) and *birc5b* ATG-MO (**l**) 48 h.p.f. embryos. The loss of neural differentiation in *birc5a* and *birc5b* MO embryos was confirmed by the deficiency in post-mitotic HuC/D expression. (**m** and **n**) Transverse brain sections with TUNEL staining in 48 h.p.f. *hif2α* ATG-MO embryos injected with 50 pg of *birc5a* mRNA (**m**) or *birc5b* mRNA (**n**). The intensive apoptosis observed in the *hif2α* morphants was effectively eliminated by either ectopic addition of *birc5a* or *birc5b* mRNA. (**o** and **p**), Lateral views of *elavl3* expression in 24 h.p.f. *hif2α* ATG-MO embryos injected with 50 pg of *birc5a* mRNA (**o**) and *birc5b* mRNA (**p**). (**q** and **r**) Immunofluorescent staining of HuC/HuD in transverse brain sections of 48 h.p.f. *hif2α* ATG-MO embryos injected with 50 pg of *birc5a* mRNA (**q**) and *birc5b* mRNA (**r**). The loss of *elavl3* expression in *hif2α* morphants was rescued by *in vitro* transcribed *birc5a* or *birc5b* mRNA](cdd201144f6){#fig6}

![DNA content analysis by flow cytometry. For each sample, 30 000 events were acquired. In WT 48 h.p.f. embryos (**a**), 72, 25 and 3% of cells were in the G0/G1 (2*n*), S (2*n*∼4*n*) and G2/M (4*n*) phases, respectively; 5% apoptotic cells (\<2*n*) were detected among the WT cells. *hif2α* (**b**) and *birc5a* (**c**) ATG-MO treatments increased the percentage of cells in S and G2/M compared with WT embryos. The percentage of apoptotic cells also increased by 3--4-fold compared with WT embryos. Treatment with 50 pg of ectopic *birc5a* mRNA (**d**) reduced *hif2α* ATG-MO-induced cell death to a level comparable to wild-type embryos. The percentage of cells in the S and G2/M phases also decreased significantly compared with *hif2α* and *birc5a* morphants](cdd201144f7){#fig7}

![CNS defects in *hif2α* morphants are rescued by ectopic injection of survivin orthologue mRNA. The percentages of normal, moderate and severe (characterized by a smaller head size, short curved tail, narrow somites and massive CNS apoptosis) morphological phenotypes in the WT (*n*=50), *hif1α* ATG-MO (*n*=54), *hif2α* ATG-MO (*n*=69), *hif2α* SPL-MO (*n*=23), *hif3α* ATG-MO (*n*=25), *hif1α, 3α* dual ATG-MO (*n*=64), *birc5a* ATG-MO (*n*=45), *birc5b* ATG-MO (*n*=35) 48 h.p.f. embryos and *hif2α* ATG-MO co-injected with 50 pg *birc5a* mRNA (*n*=167) and in the *hif2α* ATG-MO embryos co-injected with 50 pg *birc5b* mRNA (*n*=262). Ectopic injection of either *birc5a* or *birc5b* mRNA restored most *hif2α* morphants to a normal phenotype whereas *birc5a* mRNA had better rescuing capability](cdd201144f8){#fig8}

![Knockdown of *birc5a* and *birc5b* maintains neural progenitor cells in a proliferating stage and blocks maturation. (**a**--**c**) Lateral views of *nes* expression in WT (**a**), *birc5a* ATG-MO (**b**) and *birc5b* ATG-MO (**c**) 48 h.p.f. embryos. (**d**--**f**) Lateral views of *pcna* expression in WT (**d**), *birc5a* ATG-MO (**e**) and *birc5b* ATG-MO (**f**) 48 h.p.f. embryos. (**g**--**i**) Immunofluorescent staining of PCNA (in red) in transverse brain sections of WT (**g**), *birc5a* ATG-MO (**h**) and *birc5b* ATG-MO (**i**) 48 h.p.f. embryos. Nuclei are labeled by DAPI staining (blue). The high levels of *nes* and *pcna* expression following treatment with *birc5a* and *birc5b* MOs indicate that the NPCs are proliferating and not terminally differentiated. (**j**--**o**) Lateral views of *cdkn1b* (**j**--**l**) and *cdkn1c* (**m**--**o**) expression in WT (**j** and **m**), *birc5a* ATG-MO (**k** and **n**) and *birc5b* ATG-MO (**l** and **o**) 48 h.p.f. embryos. (**p**--**r**) Lateral views of *ccnd1* expression in WT (**p**), *birc5a* ATG-MO (**q**) and *birc5b* ATG-MO (**r**) 48 h.p.f. embryos. The reduction in *cdkn1b* and *cdkn1c* expression and increase in *ccnd1* expression in the CNS following treatment with *birc5a* and *birc5b* MOs suggest that the NPCs failed to exit from the cell cycle](cdd201144f9){#fig9}

![HIF2*α* binds to *birc5a* and *birc5b* promoter. (**a**) HIF2*α* binds to HRE as confirmed by EMSA. COS-1 cells were transfected with zHif2A-HA and zARNT1A-HA as indicated. Nuclear extracts were collected at 48 h post-transfection followed by gel mobility shift assays by using the HRE oligonucleotides as a probe. The asterisks in lanes 3, 4 and 6 indicate the specific HIF2--HRE complex formed. NE, nuclear extract; COS-1, nuclear extract of COS-1 cells without transfection as a control; Hif2A, nuclear extract of COS-1 cells transfected with pcDNA3-zHif2A-HA; Hif2A+zARNT1A, nuclear extract of COS-1 cells co-transfected with pcDNA3-zHif2A-HA and pcDNA3-zARNT1A-HA. (**b**) HIF2*α* binds to the *birc5a* and *birc5b* promoters in brain tissues under physiological conditions. A chromatin immunoprecipitation (ChIP) assay was performed with polyclonal antibody against anti-HIF2*α* or preimmune serum as control. Chromatin was prepared from adult brain tissue and then immunoprecipitated using polyclonal antibody against anti-HIF2*α* or preimmune serum (IgG) as control. The immunoprecipitates were subjected to PCR using specific primers spanning the HREs in the *birc5a* and *birc5b* promoters (shown in panel **c**). The module 5 of *birc5a* and modules 2 and 6 of *birc5b* were significantly enriched by the HIF2*α* antibody. The rest modules failed to be amplified. A portion of chromatin solution (2.4%) was used as input. The primers used in ChIP assay were listed in [Table 1](#tbl1){ref-type="table"}. (**c**) Schematic representation of the *birc5a* (NM_194397), *birc5b* (NM_145195), human *BIRC5* (NM_001012271) and mouse *Birc5* (NM_001012273) promoters. The putative binding sites for HIF2, including HRE1 (ACGTG, black bars) and HRE2 (GCGTG, gray bars), are indicated. The position of the DNA modules analyzed in ChIP-PCR assays is indicated by the boxes. The amplified fragments in ChIP assays (panel **b**), including the module 5 in *birc5a* promoter and the modules 2 and 6 in *birc5b* promoter, are indicated by black boxes](cdd201144f10){#fig10}

![A proposed mechanism by which HIF2*α* deprivation induces NPC apoptosis and blocks neural differentiation. Knockdown of *hif2α* results in a reduction in the survivin orthologues, which in turn causes apoptosis and induces complementary proliferation in neighboring cells. The replenished proliferating cells remain in the cell cycle and do not terminally differentiate](cdd201144f11){#fig11}

###### Primer sequences used in ChIP assay

  **Module**   **Forward**                 **Reverse**              **Positions**
  ------------ --------------------------- ----------------------- ----------------
  5a-1         CTACATGCTGTGGTCGAACT        CCAACCGACGAATGTTTGAA      +70∼−169 bp
  5a-2         ACGTGCTGGATAAGTTGACG        ATCATTGCCACTTGACCATG     −2258∼−2453 bp
  5a-3         TGGTTACCAGGTTCTAGCTC        CTCCAGAATTAAGAGACAGG     −3397∼−3568 bp
  5a-4         GTATGTGTCCAGCAGTGGTT        TCTCTCCGTCTCCTTTCAGA     −4085∼−4239 bp
  5a-5         AGACTCATCAGACCAGGCAA        GCAGAAGAGCTTCTCTGAAT     −5447∼−5628 bp
  5a-6         CTAACCACTGAGCCACCTAA        GCATCATAGATGTGCAGCAG     −6051∼−6303 bp
  5a-7         GGCTATGTTTGCCACCACAA        AGGACTCATTACAGCGCATTC    −7104∼−7267 bp
  5a-8         ATCCAGTCAACAGCCACAGA        GAAGGGTTAACAATGCTGAC     −9678∼−9803 bp
                                                                           
  5b-1         GAGACATCGTCCTTCAAAC         CTTCGCTGTAAGATGACACA      −189∼−357 bp
  5b-2         CCATTCCTTTATGACCACAG        CTGCACGTACATGATGTGAA     −1262∼−1475 bp
  5b-3         CAGCTTGTTAAGGATCAGGC        GTTGCTTCCATGTGATTGGC     −1961∼−2123 bp
  5b-4         CTGGTTCATTCCGCTGTGAT        GACTGAATTGTGTGGAACCC     −4357∼−4561 bp
  5b-5         CACTGTACCAGTTTGTCTGG        CTAAACCCAACGGACAGTGT     −5162∼−5363 bp
  5b-6         GGTGTAAGTAGTGTGTTCAC        GCAAAGCTGAGGTAGTTGAG     −7197∼−7333 bp
  5b-7         ACTTCCATGTGTGAACCAGC        CTTCAACTGTACGTGTTCAC     −7960∼−8072 bp
  5b-8         GCAGAGAAGCATACTAATATGTTGA   AGGAGATTCCTCCCATTGTG     −8489∼−8682 bp

[^1]: Current address: Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan, ROC.
